Morphine Sulfate Capsule, Extended Release
NDC Package 0832-0233-50
Package Information
Morphine Sulfate capsules is a medication used to treat severe pain. This formulation utilizes a capsule, extended release delivery system. Marketed by Upsher-smith Laboratories, Llc, this product is identified by NDC 0832-0233 and is authorized under FDA application ANDA202104.
Identification & Billing
- RxCUI: 892345 - morphine sulfate 30 MG Extended Release Oral Capsule
- RxCUI: 892345 - MS 30 MG Extended Release Oral Capsule
- RxCUI: 892352 - morphine sulfate 60 MG Extended Release Oral Capsule
- RxCUI: 892352 - morphine sulfate 60 MG 12-24 HR Extended Release Oral Capsule
- RxCUI: 892352 - MS 60 MG Extended Release Oral Capsule
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 0832 - Upsher-smith Laboratories, Llc
- 0832-0233 - Morphine Sulfate
- 0832-0233-50 - 500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE
- 0832-0233 - Morphine Sulfate
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (0832-0233). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 0832-0233-50 identifies a specific commercial package of 500 capsule, extended release in 1 bottle of Morphine Sulfate, a human prescription drug labeled by Upsher-smith Laboratories, Llc. This capsule, extended release is formulated for oral use and contains morphine sulfate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Upsher-smith Laboratories, Llc on June 30, 2013. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
This medication is used to treat severe pain. Morphine belongs to a class of drugs known as opioid analgesics. It works in the brain to change how your body feels and responds to pain.
How is this Upsher-smith Laboratories, Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 00832023350. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 500 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.